{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:55:01Z","timestamp":1776790501195,"version":"3.51.2"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40121-020-00363-w","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T04:18:16Z","timestamp":1604290696000},"page":"253-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes: A Prospective Cohort Study"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2459-1485","authenticated-orcid":false,"given":"Laila Carolina","family":"Abu Esba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahaf Ali","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abin","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nour","family":"Shamas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lolowa","family":"Alswaidan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gahdah","family":"Mardawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,2]]},"reference":[{"key":"363_CR1","unstructured":"Times P. Managing and Treating Fever: A Guide to Nonprescription Antipyretics 2018. https:\/\/www.pharmacytimes.com\/publications\/issue\/2018\/February2018\/managing-and-treating-fever-a-guide-to-nonprescription-antipyretics. Accessed 19 March 2020."},{"key":"363_CR2","unstructured":"Chandler M. Global ibuprofen shortage hits UK supermarkets\u2014with shelves left empty. 2019. https:\/\/www.mirror.co.uk\/news\/uk-news\/global-ibuprofen-shortage-hits-uk-20465178. Accessed 1 April 2020."},{"key":"363_CR3","unstructured":"News B. Coronavirus and ibuprofen: separating fact from fiction. 2020. https:\/\/www.bbc.com\/news\/51929628. Accessed 1 April 2020."},{"key":"363_CR4","unstructured":"Today U. Fact check: does using ibuprofen when you have coronavirus make symptoms worse? 2020. https:\/\/www.usatoday.com\/story\/news\/factcheck\/2020\/03\/18\/fact-check-coronavirus-and-ibuprofen-do-nsaids-make-coronavirus-worse\/2865866001\/. Accessed 1 April 2020."},{"key":"363_CR5","unstructured":"News N. Concerned about taking ibuprofen for coronavirus symptoms? Here's What Experts Say. 2020. https:\/\/www.npr.org\/sections\/health-shots\/2020\/03\/18\/818026613\/advice-from-france-to-avoid-ibuprofen-for-covid-19-leaves-experts-baffled. Accessed 1 April 2020."},{"key":"363_CR6","unstructured":"Willsher K. Anti-inflammatories may aggravate Covid-19, France advises. 2020. https:\/\/www.theguardian.com\/world\/2020\/mar\/14\/anti-inflammatory-drugs-may-aggravate-coronavirus-infection. Accessed 1 April 2020."},{"issue":"4","key":"363_CR7","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21.","journal-title":"Lancet Respir Med"},{"key":"363_CR8","unstructured":"Agency EM. EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19. 2020. https:\/\/www.ema.europa.eu\/en\/news\/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19. Accessed 3 May 2020."},{"key":"363_CR9","doi-asserted-by":"publisher","unstructured":"Castro VM, Ross RA, McBride SM, Perlis RH. Identifying common pharmacotherapies associated with reduced COVID-19 morbidity using electronic health records. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.04.11.20061994","DOI":"10.1101\/2020.04.11.20061994"},{"key":"363_CR10","unstructured":"DRUG USF. FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19. 2020. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19. Accessed 3 May 2020."},{"key":"363_CR11","unstructured":"GOV.UK. Commission on Human Medicines advice on ibuprofen and coronavirus (COVID-19). 2020. https:\/\/www.gov.uk\/government\/news\/commission-on-human-medicines-advice-on-ibuprofen-and-coronavirus-covid-19. Accessed 3 May 2020."},{"key":"363_CR12","doi-asserted-by":"publisher","unstructured":"Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94(7):e00127\u201320. PMID: 31996437; PMCID: PMC7081895. https:\/\/doi.org\/10.1128\/JVI.00127-20","DOI":"10.1128\/JVI.00127-20"},{"issue":"2","key":"363_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000375362","volume":"131","author":"W Qiao","year":"2015","unstructured":"Qiao W, Wang C, Chen B, Zhang F, Liu Y, Lu Q, et al. Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats. Cardiology. 2015;131(2):97\u2013106.","journal-title":"Cardiology"},{"issue":"4","key":"363_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/pds.983","volume":"14","author":"R Paulose-Ram","year":"2005","unstructured":"Paulose-Ram R, Hirsch R, Dillon C, Gu Q. Frequent monthly use of selected non-prescription and prescription non-narcotic analgesics among US adults. Pharmacoepidemiol Drug Saf. 2005;14(4):257\u201366.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"8","key":"363_CR15","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/pds.732","volume":"11","author":"GC Curhan","year":"2002","unstructured":"Curhan GC, Bullock AJ, Hankinson SE, Willett WC, Speizer FE, Stampfer MJ. Frequency of use of acetaminophen, nonsteroidal anti-inflammatory drugs, and aspirin in US women. Pharmacoepidemiol Drug Saf. 2002;11(8):687\u201393.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"363_CR16","doi-asserted-by":"publisher","first-page":"7027","DOI":"10.1038\/srep07027","volume":"4","author":"P Yang","year":"2014","unstructured":"Yang P, Gu H, Zhao Z, Wang W, Cao B, Lai C, et al. Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury. Sci Rep. 2014;4:7027.","journal-title":"Sci Rep"},{"issue":"8","key":"363_CR17","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury. Nat Med. 2005;11(8):875\u20139.","journal-title":"Nat Med"},{"issue":"1","key":"363_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-017-1823-x","volume":"21","author":"A Khan","year":"2017","unstructured":"Khan A, Benthin C, Zeno B, Albertson TE, Boyd J, Christie JD, et al. A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Crit Care. 2017;21(1):1\u20139.","journal-title":"Crit Care"},{"key":"363_CR19","unstructured":"Worl Health Organization WH. R&D Blueprint and COVID-19. 2020. https:\/\/www.who.int\/teams\/blueprint\/covid-19. Accessed 12 June 2020."},{"key":"363_CR20","doi-asserted-by":"publisher","unstructured":"Micallef J, Soeiro T, Jonville-B\u00e9ra AP. French Society of Pharmacology, Therapeutics (SFPT). Non-steroidal anti-inflammatory drugs, pharmacology and COVID-19 infection. Therapies. 2020;75(4):355-362. https:\/\/doi.org\/10.1016\/j.therap.2020.05.003","DOI":"10.1016\/j.therap.2020.05.003"},{"issue":"3","key":"363_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","volume":"63","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364\u201374.","journal-title":"Sci China Life Sci"},{"key":"363_CR22","unstructured":"ClinicalTrials.gov. LIBERATE Trial in COVID-19 (LIBERATE). 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04334629. Accessed 12 June 2020."},{"key":"363_CR23","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s10787-020-00745-z","volume":"28","author":"L Smart","year":"2020","unstructured":"Smart L, Fawkes N, Goggin P, et al. A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality. Inflammopharmacol. 2020;28:1141\u201352. https:\/\/doi.org\/10.1007\/s10787-020-00745-z.","journal-title":"Inflammopharmacol"},{"issue":"8","key":"363_CR24","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1177\/135965350601100803","volume":"11","author":"C Amici","year":"2006","unstructured":"Amici C, Di Coro A, Ciucci A, Chiappa L, Castilletti C, Martella V, et al. Indomethacin has a potent antiviral activity against SARS coronavirus. Antiviral Therapy. 2006;11(8):1021.","journal-title":"Antiviral Therapy"},{"issue":"5","key":"363_CR25","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1128\/AAC.02335-12","volume":"57","author":"N Lejal","year":"2013","unstructured":"Lejal N, Tarus B, Bouguyon E, Chenavas S, Bertho N, Delmas B, et al. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus. Antimicrob Agents Chemother. 2013;57(5):2231\u201342.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"363_CR26","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.celrep.2019.04.053","volume":"27","author":"W Zheng","year":"2019","unstructured":"Zheng W, Fan W, Zhang S, Jiao P, Shang Y, Cui L, et al. Naproxen exhibits broad anti-influenza virus activity in mice by impeding viral nucleoprotein nuclear export. Cell Rep. 2019;27(6):1875-855.e5.","journal-title":"Cell Rep."},{"key":"363_CR27","doi-asserted-by":"crossref","unstructured":"SafiDahaj F. RE: Response to the emerging novel coronavirus outbreak: British Medical Journal Publishing Group. 2020. https:\/\/www.bmj.com\/content\/368\/bmj.m406\/rapid-responses. Accessed 12 June 2020.","DOI":"10.1136\/bmj.m406"},{"key":"363_CR28","unstructured":"ClinicalTrials.gov. Efficacy of addition of naproxen in the treatment of critically ill patients hospitalized for COVID-19 infection (ENACOVID). 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04325633. Accessed 12 June 2020."}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-020-00363-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40121-020-00363-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-020-00363-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T03:37:11Z","timestamp":1669433831000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40121-020-00363-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["363"],"URL":"https:\/\/doi.org\/10.1007\/s40121-020-00363-w","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,2]]},"assertion":[{"value":"17 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}